News

Eli Lilly Shares Up 13% After Weight Loss Pill Appears As Effective As Ozempic And Mounjaro In Trials
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
The Grand Junction Daily Sentinel9d
First Weight-Loss Pill From Lilly Shows Promising Results
at the highest dose The pill could make treatment easier for people who don’t want to inject themselves FRIDAY, April 18, ...
The Independent on MSN1d
What you need to know about weight loss jabs and how to make them work effectively
In what feels like the biggest health craze in years, weight loss jabs like semaglutide (Ozempic and Wegovy) or tirzepatide ...
Eli Lilly's Experimental Weight Loss Pill Succeeded in Its First Pivotal Trial. Is It Time to Buy?
Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...
Verywell Health on MSN8d
Daily GLP-1 Pill Shows Promise for Diabetes and Weight Loss, Eli Lilly Says
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
inews.co.uk on MSN8d
Who could take new weight-loss pill - and who should avoid it
Eli Lilly said its drugs showed no signs of live injury in the trial. This is welcome news for researchers after Pfizer ...
The St. Louis American4d
Deciding on weight-loss medication
With the growing popularity of weight loss medications, many people are turning to prescription options to help them achieve their health goals. Medications like Ozempic, Mounjaro, and Wegovy are ...
Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Daily weight-loss pill could fix Britain’s obesity problem
A “game-changing” Ozempic-style daily pill could transform public health in Britain, experts have said. The drug is expected ...
Eli Lilly jumps as results from weight-loss pill study rival competitor’s
Shares of Eli Lilly (LLY) jumped on Thursday morning after the company announced topline Phase 3 results from ACHIEVE-1, evaluating the safety ...